Olaplex (NASDAQ:OLPX) Upgraded to “Hold” at Wall Street Zen

Wall Street Zen upgraded shares of Olaplex (NASDAQ:OLPXFree Report) from a sell rating to a hold rating in a report issued on Saturday morning.

A number of other analysts have also commented on the company. Telsey Advisory Group reaffirmed a “market perform” rating and set a $2.00 price objective on shares of Olaplex in a research note on Monday, March 2nd. Jefferies Financial Group restated a “buy” rating on shares of Olaplex in a report on Wednesday. Evercore set a $2.50 price target on shares of Olaplex in a report on Friday. Weiss Ratings reissued a “sell (d)” rating on shares of Olaplex in a research note on Thursday, January 22nd. Finally, Zacks Research raised shares of Olaplex from a “strong sell” rating to a “hold” rating in a research note on Thursday, February 19th. One equities research analyst has rated the stock with a Strong Buy rating, two have issued a Buy rating, three have assigned a Hold rating and one has given a Sell rating to the company’s stock. Based on data from MarketBeat.com, the company presently has a consensus rating of “Hold” and a consensus target price of $1.96.

Check Out Our Latest Report on Olaplex

Olaplex Stock Performance

NASDAQ:OLPX opened at $1.35 on Friday. The company has a current ratio of 4.16, a quick ratio of 3.52 and a debt-to-equity ratio of 0.40. The company has a market capitalization of $897.80 million, a P/E ratio of -134.50 and a beta of 2.24. The firm has a 50-day moving average price of $1.55 and a two-hundred day moving average price of $1.36. Olaplex has a twelve month low of $0.99 and a twelve month high of $1.84.

Olaplex (NASDAQ:OLPXGet Free Report) last issued its quarterly earnings data on Thursday, March 5th. The company reported $0.01 earnings per share (EPS) for the quarter, hitting the consensus estimate of $0.01. The firm had revenue of $105.12 million during the quarter, compared to the consensus estimate of $104.21 million. Olaplex had a positive return on equity of 1.07% and a negative net margin of 2.19%.The company’s quarterly revenue was up 4.4% compared to the same quarter last year. During the same period in the previous year, the firm posted $0.01 EPS. As a group, research analysts expect that Olaplex will post 0.1 earnings per share for the current fiscal year.

Institutional Investors Weigh In On Olaplex

A number of hedge funds have recently bought and sold shares of OLPX. Archon Capital Management LLC raised its position in shares of Olaplex by 40.4% in the 4th quarter. Archon Capital Management LLC now owns 4,466,876 shares of the company’s stock valued at $5,986,000 after purchasing an additional 1,284,557 shares in the last quarter. Geode Capital Management LLC increased its stake in shares of Olaplex by 2.8% in the fourth quarter. Geode Capital Management LLC now owns 3,865,034 shares of the company’s stock worth $5,180,000 after buying an additional 106,048 shares during the last quarter. Portolan Capital Management LLC raised its holdings in Olaplex by 132.6% in the third quarter. Portolan Capital Management LLC now owns 3,635,124 shares of the company’s stock valued at $4,762,000 after acquiring an additional 2,072,383 shares in the last quarter. Ninety One UK Ltd boosted its stake in Olaplex by 4.1% during the 4th quarter. Ninety One UK Ltd now owns 3,525,027 shares of the company’s stock valued at $4,724,000 after acquiring an additional 139,109 shares during the last quarter. Finally, State Street Corp grew its holdings in Olaplex by 3.5% during the 4th quarter. State Street Corp now owns 3,059,988 shares of the company’s stock worth $4,100,000 after acquiring an additional 103,875 shares in the last quarter. Institutional investors and hedge funds own 87.37% of the company’s stock.

Trending Headlines about Olaplex

Here are the key news stories impacting Olaplex this week:

  • Positive Sentiment: Q4 results showed revenue and EPS roughly in line with or slightly above expectations (revenue of $105.1M, EPS $0.01, revenue +4.4% YoY), which supports the view that core sales are stabilizing. OLAPLEX Reports Fourth Quarter and Fiscal Year 2025 Results
  • Neutral Sentiment: Company materials — including the slide deck and earnings call transcript — are available for investors who want management’s detailed commentary on channel mix, marketing spend and strategic initiatives. These documents may clarify execution plans but have not yet convinced the market. Earnings Slide Deck / Press Release
  • Neutral Sentiment: Several published call transcripts and recaps provide additional color on product innovation and transformation initiatives management emphasized; these are useful for judging whether spend will drive re-acceleration. Q4 2025 Earnings Call Transcript
  • Negative Sentiment: FY2026 guidance came in muted: the revenue range ($414M–$435M) sits against Street expectations near $430M, leaving limited upside and triggering investor concern about growth re-acceleration. That weak forward guide is the main reason for the sharp share decline. Olaplex slides more than 20% on guidance concerns
  • Negative Sentiment: Analyst/competitive write-ups flag that growth remains uneven across channels and that heavy marketing spend has yet to produce sustained acceleration — some analysts now view the turnaround as lagging and see downside risk to the current share price. Olaplex: The Turnaround Is Lagging
  • Negative Sentiment: Market reaction has been strong; commentary and modeling from outlets note potential downside if management cannot reaccelerate revenue and margin progress given the company’s elevated marketing spend. Short-term momentum looks negative until guidance is proven conservative. OLPX Q4 deep dive: Transformation and innovation take center stage amidst muted guidance

Olaplex Company Profile

(Get Free Report)

Olaplex, Inc (NASDAQ: OLPX) is a specialty haircare company known for its patented bond-building technology designed to repair and strengthen hair from within. The company’s core offerings encompass a range of professional salon treatments and at-home maintenance products that target chemical damage, breakage and split ends. Olaplex formulations are built around a proprietary active ingredient that works at the molecular level to rebuild disulfide bonds broken during bleaching, coloring and heat styling processes.

Founded in 2014 and headquartered in Irvine, California, Olaplex initially gained traction among high-end salons before expanding into broader retail channels.

Further Reading

Analyst Recommendations for Olaplex (NASDAQ:OLPX)

Receive News & Ratings for Olaplex Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Olaplex and related companies with MarketBeat.com's FREE daily email newsletter.